Abstracts

AUTOLOGOUS NEUTRALIZING ANTIBODIES DEVELOP AFTER EARLY BUT NOT ACUTE ART INITIATION

Background: ART initiation (ARTi) in acute/early HIV limits reservoir size and diversity, preserves host immunity, and limits transmission risk, but may also limit development of HIV-specific immune responses. While the kinetics of HIV-specific immunity with ongoing viremia is described, the effect of early ARTi on autologous neutralizing antibody (anAb) development and persistence is less clear.…

NOVEL SEROASSAYS DETECT MPOX-SPECIFIC AND VACCINE-INDUCED ORTHOPOXVIRUS IMMUNITY

Background: Mpox (previously known as monkeypox) is a disease caused by the mpox virus (MPXV) belonging to the orthopoxvirus (OPXV) genus which includes smallpox and vaccinia virus (VACV). VACV-based vaccines provide protection against mpox disease but complicate differentiation of infection-specific from vaccine-induced immunity. We tested the reactivity of serum from recently vaccinated or mpox-infected individuals…

VERTICAL TRANSMISSION IN INFANTS BORN TO WOMEN WITH HIV ON ANTIRETROVIRAL TREATMENT

Background: Monitoring mother-infant pairs with HIV exposure is needed to assess effectiveness of vertical transmission prevention programmes and progress towards vertical transmission elimination. Methods: We used routinely-collected data on infants with HIV exposure, born May 2018 – April 2021 to mothers diagnosed with HIV prior to delivery, in the Western Cape, South Africa, with follow-up…

BASELINE AND TEMPORAL DIFFERENCES IN PROTEOMICS FOLLOWING SARS-CoV-2 INFECTION IN PWH

Background: COVID-19 may be more severe in persons with HIV (PWH). However, underlying biological mechanisms associated with the development of COVID-19 and its clinical severity among antiretroviral therapy (ART) treated PWH are largely unknown. Therefore, we wished to evaluate temporal changes in plasma proteins following SARS-CoV-2 infection and identify pre-infection proteomic markers associated with future…